Market Place
Sourcing Support
Cellares, Mitsui Launch First IDMO Smart Cell Factory in Japan
29 May 2025 //
BUSINESSWIRE
Cellares to Automate CRISPR-Edited CAR-T for Tumors
10 Apr 2025 //
BUSINESSWIRE
Cellares Cell Shuttle Receives FDA AMT Designation
01 Apr 2025 //
CONTRACTPHARMA
Cellares` Cell Shuttle™ gets FDA AMT Designation for Cell Therapy
01 Apr 2025 //
BUSINESSWIRE
Cellares, Cabaletta Bio Complete Rese-cel Manufacturing Program
19 Mar 2025 //
BUSINESSWIRE
Cellares Appoints Ossama as COO, Former Novartis & Lonza Leader
12 Nov 2024 //
BUSINESSWIRE
Cellares And Sony Partner On Cell Therapy Manufacturing Platform
12 Sep 2024 //
BUSINESSWIRE
Cellares Completes New cGMP Cell Shuttle in Bridgewater, NJ
05 Sep 2024 //
CONTRACT PHARMA
Cellares Completes First cGMP Cell Shuttle at IDMO Smart Factory in New Jersey
05 Sep 2024 //
BUSINESSWIRE
Cellares Appoints Justin McAnear as CFO and Jonathan Butler as General Counsel
03 Sep 2024 //
BUSINESSWIRE
Cellares Appoints CFO and General Counsel
03 Sep 2024 //
CONTRACT PHARMA
BMS Taps Cellares in $380M CAR T Cell Therapy Manufacturing Agreement
23 Apr 2024 //
PRESS RELEASE
Shaw Appointed to Cellares Advisory Board to Advance Cell Therapy Manufacturing
26 Mar 2024 //
BUSINESSWIRE
Cell therapy manufacturer Cellares gains 1st cGMP certification
12 Mar 2024 //
FIERCE PHARMA
Cellares to produce Cabaletta’s autoimmune CAR-T candidate
06 Nov 2023 //
ENDPTS
Cellares Announces Expanded Agreement with Bristol Myers Squibb
11 Oct 2023 //
BUSINESSWIRE
Copyright © 2025 LePro PharmaCompass OPC Private Limited, All rights reserved.